Published in Eur Respir J on July 01, 2004
HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev (2011) 3.28
Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy. Am J Respir Crit Care Med (2008) 2.63
Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa. AIDS (2010) 1.90
Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A (2010) 1.48
Interferon-γ release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One (2012) 1.48
Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS (2008) 1.34
Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting? J Acquir Immune Defic Syndr (2011) 1.19
Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study. Clin Exp Immunol (2007) 1.16
Predictors of death among patients who completed tuberculosis treatment: a population-based cohort study. PLoS One (2011) 1.01
Impact of previous ART and of ART initiation on outcome of HIV-associated tuberculosis. Clin Dev Immunol (2012) 0.93
Predictors of mortality in HIV-associated hospitalizations in Portugal: a hierarchical survival model. BMC Health Serv Res (2009) 0.87
High rates of tuberculosis in patients accessing HAART in rural South Africa. J Acquir Immune Defic Syndr (2014) 0.77
Tuberculosis 2004: challenges and opportunities. Trans Am Clin Climatol Assoc (2005) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med (1997) 7.11
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Prophylaxis after occupational exposure to HIV. BMJ (1997) 4.07
Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis (1997) 4.02
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis (1992) 3.95
Measles outbreak on a cruise ship in the western Mediterranean, February 2014, preliminary report. Euro Surveill (2014) 3.87
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. J Acquir Immune Defic Syndr (2001) 3.83
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J (2007) 3.67
Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis (2001) 3.51
Public health. Responding to market failures in tuberculosis control. Science (2001) 3.12
Secondary mutations in the protease region of human immunodeficiency virus and virologic failure in drug-naive patients treated with protease inhibitor-based therapy. J Infect Dis (2001) 2.50
Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J (2007) 2.46
Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis (2002) 2.44
Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2001) 2.24
Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA (1995) 2.08
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Cytotoxic necrotizing factor production by hemolytic strains of Escherichia coli causing extraintestinal infections. J Clin Microbiol (1987) 2.07
Tuberculosis control in Europe and international migration. Eur Respir J (1994) 2.07
Epidemiology and clinical features of imported dengue fever in Europe: sentinel surveillance data from TropNetEurop. Clin Infect Dis (2002) 2.02
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst (1999) 2.01
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J (2009) 2.01
Incidence of tuberculosis after HAART initiation in a cohort of HIV-positive patients in Burkina Faso. Int J Tuberc Lung Dis (2010) 1.91
Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int J Tuberc Lung Dis (1999) 1.90
Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J (2004) 1.90
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis (2002) 1.86
Inhibition of respiration under the control of azide uptake by mitochondria. Eur J Biochem (1967) 1.83
Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection. AIDS (2000) 1.82
Prevalence of infected patients and understaffing have a role in hepatitis C virus transmission in dialysis. Am J Kidney Dis (2001) 1.77
Citrin and aralar1 are Ca(2+)-stimulated aspartate/glutamate transporters in mitochondria. EMBO J (2001) 1.74
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Direct methods for measuring metabolite transport and distribution in mitochondria. Methods Enzymol (1979) 1.73
Kinetics of succinate uptake by rat-liver mitochondria. FEBS Lett (1969) 1.73
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis (1994) 1.71
Kinetic study of the dicarboxylate carrier in rat liver mitochondria. Eur J Biochem (1971) 1.71
Identification and functional reconstitution of the yeast peroxisomal adenine nucleotide transporter. EMBO J (2001) 1.68
Molecular epidemiology study of exogenous reinfection in an area with a low incidence of tuberculosis. J Clin Microbiol (2001) 1.66
High risk of tuberculosis in health care workers in Romania. Int J Tuberc Lung Dis (2008) 1.60
Quantitative correlation between the distribution of anions and the pH difference across the mitochondrial membrane. Eur J Biochem (1970) 1.56
Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exp Allergy (1996) 1.54
Neurocysticercosis in an Italian traveler to Latin America. Am J Trop Med Hyg (1999) 1.53
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS (2000) 1.52
The European network of Biosafety-Level-4 laboratories: enhancing European preparedness for new health threats. Clin Microbiol Infect (2009) 1.52
Expression in Escherichia coli, functional characterization, and tissue distribution of isoforms A and B of the phosphate carrier from bovine mitochondria. J Biol Chem (1998) 1.50
Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS (1995) 1.48
Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis (1996) 1.48
Correlation between anion uptake and the movement of K+ and H+ across the mitochondrial membrane. Eur J Biochem (1969) 1.47
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect (2006) 1.45
Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur Respir J (1999) 1.42
Identification of the yeast mitochondrial transporter for oxaloacetate and sulfate. J Biol Chem (1999) 1.42
Prevalence of hepatitis B and C viruses and human immunodeficiency virus infections in women of reproductive age. Br J Obstet Gynaecol (1992) 1.41
Abundant bacterial expression and reconstitution of an intrinsic membrane-transport protein from bovine mitochondria. Biochem J (1993) 1.40
Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection (2002) 1.39
SARS and masks. J Hosp Infect (2004) 1.39
Clustered cases of pneumonia among healthcare workers over a 1-year period in three Italian hospitals: applying the WHO SARS alert. Infection (2006) 1.39
Theoretical analysis of evolutionary algorithms with an infinite population size in continuous space. Part I: Basic properties of selection and mutation. IEEE Trans Neural Netw (1994) 1.38
AIDS in Italy. Lancet (1984) 1.38
Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. Am J Respir Crit Care Med (1994) 1.35
The transport of sulphate and sulphite in rat liver mitochondria. Biochem J (1974) 1.35
Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers. Euro Surveill (2009) 1.35
Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin Infect Dis (2006) 1.34
Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control (1995) 1.34
Peptide-specific antibodies and proteases as probes of the transmembrane topology of the bovine heart mitochondrial porin. Biochemistry (1991) 1.32
Identification of the human mitochondrial oxodicarboxylate carrier. Bacterial expression, reconstitution, functional characterization, tissue distribution, and chromosomal location. J Biol Chem (2000) 1.31
Yeast mitochondrial carriers: bacterial expression, biochemical identification and metabolic significance. J Bioenerg Biomembr (2000) 1.31
Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J Acquir Immune Defic Syndr (2001) 1.31
Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice. Am J Respir Crit Care Med (1998) 1.30
Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis (2003) 1.29
The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals. Proc Natl Acad Sci U S A (2001) 1.29
Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop. J Travel Med (2003) 1.27
Kinetics and specificity of the oxoglutarate carrier in rat-liver mitochondria. Eur J Biochem (1972) 1.26
Purification of reconstitutively active alpha-oxoglutarate carrier from pig heart mitochondria. Biochim Biophys Acta (1985) 1.25
Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Varese Tuberculosis Study Group. Eur Respir J (1995) 1.25
Identification of the yeast ACR1 gene product as a succinate-fumarate transporter essential for growth on ethanol or acetate. FEBS Lett (1997) 1.25
Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years. J Acquir Immune Defic Syndr (2001) 1.24
Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS (2000) 1.23
Mycobacterium tuberculosis DNA detection in soluble fraction of urine from pulmonary tuberculosis patients. Int J Tuberc Lung Dis (2008) 1.20
Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS (1994) 1.20
European recommendations for the management of healthcare workers occupationally exposed to hepatitis B virus and hepatitis C virus. Euro Surveill (2005) 1.20
Improving the TB case management: The International Standards for Tuberculosis Care. Eur Respir J (2006) 1.19
Early versus delayed inpatient stroke rehabilitation: a matched comparison conducted in Italy. Arch Phys Med Rehabil (2000) 1.19